Search For "controller"
Gautam Gambhir Foundation guilty of illegally hoarding COVID-19 drugs: Del
Updated : 4 years, 9 months ago IST
New Delhi [India], June 3 (ANI): The Drug Controller of Delhi on Thursday informed the Delhi High Court that Gautam Gambhir Foundation has committed an offence under the Drugs and Cosmetics Act for hoarding unauthorised stock of COVID-19 drugs.
Read More
Plea in Delhi HC seeking stay on Phase II/III clinical trial of Covaxin in
Updated : 4 years, 9 months ago IST
New Delhi [India], June 3 (ANI): A Fresh application was moved in Delhi High Court on Thursday seeking to stay the operation of the order of Drugs Controller General of India (DCGI) for conducting phase II/III clinical trials of Whole Virion Inactivated Coronavirus Vaccine in the 2 to 18 yea
Read More
SII seeks DCGI's permission for test license to manufacture Sputnik V COVI
Updated : 4 years, 9 months ago IST
New Delhi [India], June 3 (ANI): Indian vaccine manufacturing company Serum Institute of India (SII) has sought permission from the Drug Controller General of India (DCGI) for the production of the Russian vaccine Sputnik V in India.
Read More
DCGI waiver likely to bring foreign vaccines like Pfizer, Moderna a step c
Updated : 4 years, 9 months ago IST
New Delhi [India], June 2 (ANI): The Drugs Controller General of India (DCGI) has done away with specific trials of COVID-19 vaccines that have been approved by other international regulatory bodies - a big move likely to clear the way for foreign vaccines like Pfizer and Moderna for the
Read More
Delhi HC raps Drug Controller Department over probe into COVID-19 medicine
Updated : 4 years, 9 months ago IST
New Delhi [India], May 31 (ANI): Expressing dissatisfaction with its status report, the Delhi High Court on Monday pulled up the Drug Controller Department of Delhi for not properly examining how BJP MP Gautam Gambhir procured a huge quantity of COVID-19 medicines.
Read More
Zydus Cadila seeks DCGI approval for clinical trials for monoclonal antibo
Updated : 4 years, 9 months ago IST
New Delhi [India], May 27 (ANI): Zydus Cadila has sought approval from the Drugs Controller General of India (DCGI) to undertake clinical trials for monoclonal antibodies cocktail that can neutralise COVID-19 infection, the pharmaceutical manufacturer informed on Thursday.
Read More
COVID-19: MSN Laboratories initiates Phase III clinical trial of Molnupira
Updated : 4 years, 9 months ago IST
New Delhi [India], May 26 (ANI): MSN Laboratories Private Limited (MSN) is initiating phase III clinical trial of Molnupiravir capsules for the treatment of COVID-19 in India.
Read More
Karnataka: BJP youth wing demands action against Congress youth wing for i
Updated : 4 years, 10 months ago IST
Bengaluru (Karnataka) [India], May 18 (ANI): BJP youth wing in Bengaluru in a letter to state drugs controller demanded action against Congress youth wing Karnataka president MS Raksha Ramaiah and other workers alleging that they are issuing medicine kits containing drugs that can be sold
Read More
DCGI approves Phase 2, 3 clinical trials of COVAXIN on children aged 2 to
Updated : 4 years, 10 months ago IST
New Delhi [India], May 13 (ANI): The Drugs Controller General of India (DCGI) on Thursday approved Phase 2 and 3 clinical trial of Bharat Biotech's COVAXIN vaccine in the age group of 2 to 18 years, informed the Ministry of Health and Family Welfare.
Read More
DRDO's anti-COVID 2-DG drug effective against different variants: DRDO sci
Updated : 4 years, 10 months ago IST
New Delhi [India], May 8 (ANI): The Defence Research and Development Organisation (DRDO)'s new anti-COVID drug, just approved by the Drugs Controller General of India (DCGI) is effective against different variants of the coronavirus and helps in bringing patients out of oxygen support, sa
Read More
DCGI nods anti-COVID drug developed by DRDO for emergency use
Updated : 4 years, 10 months ago IST
New Delhi [India], May 8 (ANI): The Drugs Controller General of India (DCGI) has approved the emergency use of an anti-COVID drug - 2-deoxy-D-glucose (2-DG) - as an adjunct therapy in moderate to severe COVID-19 cases.
Read More
VINS Bioproducts gets DCGI nod to commence clinical trials for VINCOV-19
Updated : 4 years, 10 months ago IST
Hyderabad (Telangana) [India], April 26 (ANI): VINS Bioproducts on Monday received approval from the Drugs Controller General of India (DCGI) to commence the clinical trials for VINCOV-19, an antidote, and a cure against COVID-19, the Hyderabad based immunological company said.
Read More